Logo image of DSGN

DESIGN THERAPEUTICS INC (DSGN) Stock Analyst Ratings

NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD

3.83  -0.43 (-10.09%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to DSGN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.14. This target is 86.42% above the current price.
DSGN was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about DSGN.
In the previous month the buy percentage consensus was at a similar level.
DSGN was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

DSGN Historical Analyst RatingsDSGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -45 -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 3.834.045.107.1412.60 - 5.48% 33.16% 86.42% 228.98%

Related screens

DSGN Current Analyst RatingDSGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-08-06 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-05-07 Piper Sandler Upgrade Neutral -> Overweight
2024-03-20 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-03-20 Wedbush Reiterate Neutral -> Neutral
2023-11-14 RBC Capital Maintains Sector Perform -> Sector Perform
2023-08-15 RBC Capital Downgrade Outperform -> Sector Perform
2023-08-15 SVB Leerink Downgrade Outperform -> Market Perform
2023-08-15 Wedbush Downgrade Outperform -> Neutral
2023-05-10 RBC Capital Maintains Outperform
2023-05-10 Wedbush Maintains Outperform
2023-05-04 Goldman Sachs Upgrade Sell -> Neutral
2023-03-15 RBC Capital Reiterate Outperform
2022-12-09 SVB Leerink Maintains Outperform
2022-12-08 RBC Capital Maintains Outperform
2022-08-09 Wedbush Maintains Outperform
2022-06-10 Wedbush Initiate Outperform
2022-05-24 Goldman Sachs Maintains Sell
2022-05-10 SVB Leerink Maintains Outperform
2022-05-02 RBC Capital Initiate Outperform
2022-01-19 Goldman Sachs Initiate Sell
2021-04-20 SVB Leerink Initiate Outperform
2021-04-20 Goldman Sachs Initiate Neutral
2021-04-20 Piper Sandler Initiate Overweight